MCRS1

Microspherule protein 1 · Q96EZ8 · MCRS1 on Sugi Atlas →

0 patent compounds predicted against MCRS1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MCRS1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized) PHASE3UNKNOWN
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus PHASE2UNKNOWN
Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer PHASE2COMPLETED
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer nanACTIVE_NOT_RECRUITING
French National Cohort of Patients With PRSS1 Mutations nanRECRUITING
Salmon Peptide Fraction: Safety and Cardiometabolic Health nanCOMPLETED
PROOF: Pancreatitis-associated Risk Of Organ Failure nanCOMPLETED
Pancreatic Cancer Early Detection Consortium nanRECRUITING
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer nanCOMPLETED
MOR-1 Expression in Colorectal Cancer and Disease-free Survival Relationship. Five-year Follow-up. nanCOMPLETED
Identifying Maturity-onset Diabetes of the Young in Emirati Patients nanNOT_YET_RECRUITING
Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients nanCOMPLETED
Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia nanCOMPLETED
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations nanCOMPLETED
Hereditary Nonpolyposis Colorectal Cancer in Taiwan-Related Genetic Study and Clinical Applications nanUNKNOWN
Fecal DNA Methylation Test for Colorectal Cancer Screening nanUNKNOWN
Tissue Predictors of Abiraterone Benefit nanCOMPLETED
CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION nanUNKNOWN
Pancreatic Cancer Early Detection Program nanUNKNOWN
Long Term Prediction of MASH-related HCC Risk by Proteomics nanNOT_YET_RECRUITING
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Clinical Validation of an Immunocytochemistry Method Using MARS1 nanCOMPLETED
NSABP Patient Registry and Biospecimen Profiling Repository nanCOMPLETED
Stool Testing for Pancreatic Cancer nanCOMPLETED
The Effects of Whey vs. Collagen on MPS nanCOMPLETED
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study nanCOMPLETED
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial nanUNKNOWN
Predisposition Genes in Monogenic Diabetes (DIAMONO) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MCRS1 binder may also engage these)

ProteinNameSimilarity
Q99L90 1.000 Q99L90 →
Q9ERG2 0.968 Q9ERG2 →
HIRA Protein HIRA 0.967 landscape →
PRKD1 Serine/threonine-protein kinase D1 0.967 landscape →
Q5XIS9 0.967 Q5XIS9 →
F1LTE0 0.967 F1LTE0 →
A5D7H2 0.966 A5D7H2 →
Q9Z1T4 0.966 Q9Z1T4 →
Q61666 0.966 Q61666 →
Q5T6S3 0.966 Q5T6S3 →
Q9R1D7 0.965 Q9R1D7 →
Q9Y2X7 0.965 Q9Y2X7 →
Q01826 0.964 Q01826 →
Q2TAD4 0.964 Q2TAD4 →
Q9Z272 0.964 Q9Z272 →
A2A690 0.964 A2A690 →
Q5SQF8 0.963 Q5SQF8 →
Q9HCD6 0.963 Q9HCD6 →
Q3KR37 0.963 Q3KR37 →
Q62101 0.963 Q62101 →
P84060 0.963 P84060 →
Q13033 0.962 Q13033 →
Q14161 0.962 Q14161 →
Q5R467 0.962 Q5R467 →
Q9HCE6 0.962 Q9HCE6 →
Q9UQB8 0.962 Q9UQB8 →
Q60611 0.962 Q60611 →
Q6IE70 0.962 Q6IE70 →
P58405 0.962 P58405 →
Q66H91 0.962 Q66H91 →